Description
Microbiome Cosmetic Products Market—Forecast till 2028
Market Overview
The microbiome cosmetic products market is anticipated to witness a notable CAGR of 6.60% to surpass a value of USD 57,469.9 thousand during the forecast period (2028). The microbiome is characterized as an assortment of microorganisms that live in a specific spot. Microbiome cosmetic products allude to cosmetic products that cultivate a solid skin microbiome. These organisms shield the skin from microbes, control skin invulnerability, nutrient retention, and backing the skin hindrance.
The worldwide microbiome cosmetic products market saw huge development throughout the course of recent years and is projected to enroll a 6.60% CAGR during the review time frame. The significant development drivers are the emphasis on sound maturing, interest in ensured products, and rising interest in normal fixings in the cosmetic business. In any case, premium evaluation of products and issues regarding viability is set to check the market development of microbiome cosmetic products. By and by, the development of the coordinated retail area in emerging countries is supposed to set out rewarding development and open doors for players working in the microbiome cosmetic products market during the conjecture time frame.
Segment Overview
The microbial component divides the global microbiome cosmetic products market into lactobacillus, lactococcus, streptococcus, acetobacter, leuconostoc, bifidobacterium, saccharomyces, bacillus, pediococcus, zygosaccharomyces, aspergillus, micrococcus, and others. The ingredient segment is made up of probiotic, prebiotic, and postbiotic. The postbiotic segment is sub-segmented as ferment extract, and ferment extract filtrate), extract (extract filtrate and filtrate), ferment (ferment lysate, ferment filtrate, ferment lysate filtrate,lysate (lysate filtrate, lysate extract, and spores), and others.
By format, the market is categorized into cream/lotion, serum, cleanser/face wash, spot treatment, masks, skin tonic/toner, face oil, scrubs, sunscreen, supplements, mist/spray, pads/wipes, gels, and others. In terms of claim, the is classified into acne, hydration, smooth/brighten, environmental damage, cellular aging, wound healing, atopic dermatitis, eczema, rosacea, psoriasis, and others. The consumer group segment bifurcates the market into women and men. The women segment accounted for a larger market share of 76.43% in 2020 and is projected to register a CAGR of 6.53% during the forecast period. The age segment is categorized as babies (0-4), children (5-12), gen z (13 – 24), millennials (25-40), gen x (41-56), baby boomers (57-75), and post-war cohort (+75). The distribution channel divides the global microbiome cosmetic products market into online channels, drug stores & pharmacies, specialty stores, supermarkets & hypermarkets, department stores, and others.
Regional Analysis
Europe represented a vast majority of 38.51% of the worldwide microbiome cosmetic products market in 2020, and the pattern is supposed to go on all through the estimated period.
The developing cosmetics and individual consideration industry in Asia-Pacific, with flood popularity for skincare and medical care products combined with rising per capita discretionary cash flow and evolving ways of life, presents further open doors for market development.
Major Players
The key competitors in the global microbiome cosmetic products market include DSM (Netherland), BASF SE (Germany), Sabsinsa Corporation (US), Rolemi HPC (Italy), Puripharm. (China), L’oreal S.A.(France), HeIQ (Switzerland), Silab (France), Amorepacific Group (South Korea), TULA Life Inc. (US), Gallinée Microbiome Skincare (UK), ESSE SKINCARE (South Africa), Yun Perobiotherapy (Belgium), Estée Lauder Companies Inc. (US), Symrise (Germany), Clariant (Switzerland), Lallemand Inc. (Canada),Aurelia Skincare Ltd (UK), LaFlore Probiotic Skincare (US), Neogenlab (US).
Table of Contents
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 21
1.1 MARKET ATTRACTIVENESS ANALYSIS 22
1.1.1 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY MICROBIAL COMPONENT 23
1.1.2 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY INGREDIENT 24
1.1.3 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY FORMAT 25
1.1.4 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY CLAIM 26
1.1.5 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY CONSUMER GROUP 27
1.1.6 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY AGE 28
1.1.7 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, DISTRIBUTION CHANNEL 29
1.1.8 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY REGION 30
2 MARKET INTRODUCTION 31
2.1 DEFINITION 31
2.2 SCOPE OF THE STUDY 31
2.3 RESEARCH OBJECTIVE 31
2.4 MARKET STRUCTURE 32
2.5 KEY BUYING CRITERIA 33
3 RESEARCH METHODOLOGY 34
3.1 RESEARCH PROCESS 34
3.2 PRIMARY RESEARCH 35
3.3 SECONDARY RESEARCH 36
3.4 MARKET SIZE ESTIMATION 37
3.5 FORECAST MODEL 38
3.6 LIST OF ASSUMPTIONS & LIMITATIONS 39
4 MARKET DYNAMICS 40
4.1 INTRODUCTION 40
4.2 DRIVERS 41
4.2.1 GROWING SHARE OF GERIATRIC POPULATION WITH AN INCREASING FOCUS ON HEALTHY AGING 41
4.2.2 RISING DEMAND FOR NATURAL INGREDIENTS IN THE COSMETIC INDUSTRY 41
4.2.3 DRIVERS IMPACT ANALYSIS 42
4.3 RESTRAINTS 42
4.3.1 PREMIUM PRICING OF PRODUCTS 42
4.3.2 ISSUES REGARDING EFFICACY 42
4.3.3 RESTRAINTS IMPACT ANALYSIS 43
4.4 OPPORTUNITIES 43
4.4.1 GROWTH OF THE ORGANIZED RETAIL SECTOR IN DEVELOPING NATIONS 43
5 MARKET FACTOR ANALYSIS 45
5.1 VALUE CHAIN ANALYSIS 45
5.1.1 RAW MATERIAL PROCUREMENT 47
5.1.2 PROCESSING 47
5.1.3 PACKAGING 47
5.1.4 RAW MATERIAL PROCUREMENT 48
5.1.5 PROCESSING 49
5.1.6 PACKAGING 49
5.2 SUPPLY CHAIN ANALYSIS 50
5.3 PORTER’S FIVE FORCES MODEL 52
5.3.1 THREAT OF NEW ENTRANTS 52
5.3.2 BARGAINING POWER OF SUPPLIERS 53
5.3.3 BARGAINING POWER OF BUYERS 53
5.3.4 THREAT OF SUBSTITUTES 53
5.3.5 INTENSITY OF RIVALRY 54
5.4 IMPACT OF THE COVID-19 OUTBREAK ON GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET 54
5.4.1 OVERVIEW 54
5.4.2 IMPACT ON PRODUCTION 54
5.4.3 IMPACT ON SUPPLY-CHAIN 55
5.4.4 IMPACT ON PRICING 55
5.4.5 IMPACT ON CONSUMER BUYING BEHAVIOR 55
5.5 REGULATORY LANDSCAPE 56
5.6 PRICING OF MICROBIOME COSMETIC PRODUCTS 57
5.6.1 NORTH AMERICA 57
5.6.2 EUROPE 58
5.6.3 ASIA-PACIFIC 59
5.6.4 REST OF THE WORLD 60
6 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY MICROBIAL COMPONENT 61
6.1 OVERVIEW 61
6.1.1 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET ESTIMATES & FORECAST, BY MICROBIAL COMPONENT, 2019–2028 62
6.2 LACTOBACILLUS 63
6.3 LACTOCOCCUS 63
6.4 STREPTOCOCCUS 63
6.5 ACETOBACTER 64
6.6 LEUCONOSTOC 64
6.7 BIFIDOBACTERIUM 64
6.8 SACCHAROMYCES 65
6.9 BACILLUS 65
6.10 PEDIOCOCCUS 65
6.11 ZYGOSACCHAROMYCES 66
6.12 ASPERGILLUS 66
6.13 MICROCOCCUS 66
6.14 OTHERS 67
7 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY MICROBIAL COMPONENT 68
7.1 OVERVIEW 68
7.1.1 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET ESTIMATES & FORECAST, BY INGREDIENT, 2019–2028 69
7.2 PROBIOTIC 70
7.3 PREBIOTIC 70
7.4 POSTBIOTIC 71
8 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY FORMAT 72
8.1 OVERVIEW 72
8.1.1 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET ESTIMATES & FORECAST, BY FORMAT, 2019–2028 73
8.2 CREAM/LOTION 74
8.3 SERUM 74
8.4 CLEANSER/FACE WASH 74
8.5 SPOT TREATMENT 75
8.6 MASKS 75
8.7 SKIN TONIC/TONER 75
8.8 FACE OIL 76
8.9 SCRUBS 76
8.10 SUNSCREEN 76
8.11 SUPPLEMENTS 77
8.12 MIST/SPRAY 77
8.13 PADS/WIPES 77
8.14 GELS 78
8.15 OTHERS 78
9 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY CLAIM 79
9.1 OVERVIEW 79
9.1.1 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET ESTIMATES & FORECAST, BY CLAIM, 2019–2028 80
9.2 ACNE 81
9.3 HYDRATION 81
9.4 SMOOTH/BRIGHTEN 81
9.5 ENVIRONMENTAL DAMAGE 82
9.6 CELLULAR AGING 82
9.7 WOUND HEALING 82
9.8 ATOPIC DERMATITIS 83
9.9 ECZEMA 83
9.10 ROSACEA 83
9.11 PSORIASIS 84
9.12 OTHERS 84
10 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY CONSUMER GROUP 85
10.1 OVERVIEW 85
10.1.1 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET ESTIMATES & FORECAST, BY CONSUMER GROUP,
2019–2028 86
10.2 WOMEN 86
10.3 MEN 87
11 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY AGE 88
11.1 OVERVIEW 88
11.1.1 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET ESTIMATES & FORECAST, BY AGE, 2019–2028 89
11.2 BABIES 90
11.3 CHILDREN 90
11.4 GEN Z 90
11.5 MILLENNIALS 91
11.6 GEN X 91
11.7 BABY BOOMERS 91
11.8 POST-WAR COHORT 92
12 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY DISTRIBUTION CHANNEL 93
12.1 OVERVIEW 93
12.1.1 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL,
2019–2028 94
12.2 ONLINE CHANNELS 95
12.3 DRUG STORES & PHARMACIES 95
12.4 SPECIALTY STORES 95
12.5 SUPERMARKETS & HYPERMARKETS 96
12.6 DEPARTMENT STORES 96
12.7 OTHERS 96
13 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY REGION 97
13.1 OVERVIEW 97
13.1.1 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET ESTIMATES & FORECAST, BY REGION, 2019–2028 98
13.2 NORTH AMERICA 99
13.2.1 US 104
13.2.2 CANADA 107
13.2.3 MEXICO 111
13.3 EUROPE 115
13.3.1 UK 120
13.3.2 GERMANY 123
13.3.3 FRANCE 127
13.3.4 ITALY 130
13.3.5 SPAIN 133
13.3.6 REST OF EUROPE 137
13.4 ASIA-PACIFIC 141
13.4.1 CHINA 146
13.4.2 INDIA 149
13.4.3 JAPAN 152
13.4.4 AUSTRALIA & NEW ZEALAND 156
13.4.5 REST OF ASIA-PACIFIC 160
13.5 REST OF THE WORLD 164
13.5.1 SOUTH AMERICA 168
13.5.2 MIDDLE EAST 172
13.5.3 AFRICA 175
14 COMPETITIVE LANDSCAPE 179
14.1 INTRODUCTION 179
14.1.1 MARKET STRATEGY ANALYSIS 179
14.2 COMPETITIVE BENCHMARKING 180
14.3 KEY DEVELOPMENTS & GROWTH STRATEGIES 181
14.3.1 PRODUCT DEVELOPMENTS 181
14.3.2 ACQUISITIONS 182
14.3.3 CONTRACT & AGREEMENT 183
14.3.4 JOIN VENTURE 184
14.3.5 EXPANSIONS 184
14.3.6 PARTNERSHIPS 184
14.3.7 DIVESTMENTS 185
14.3.8 RESEARCH & DEVELOPMENT 185
15 COMPANY PROFILES OF MANUFACTURERS 186
15.1 DSM 186
15.1.1 COMPANY OVERVIEW 186
15.1.2 FINANCIAL OVERVIEW 187
15.1.3 PRODUCTS OFFERED 187
15.1.4 KEY DEVELOPMENTS 188
15.1.5 SWOT ANALYSIS 189
15.1.6 KEY STRATEGIES 189
15.2 BASF SE 190
15.2.1 COMPANY OVERVIEW 190
15.2.2 FINANCIAL OVERVIEW 190
15.2.3 PRODUCTS OFFERED 191
15.2.4 KEY DEVELOPMENTS 191
15.2.5 SWOT ANALYSIS 192
15.2.6 KEY STRATEGIES 192
15.3 SYMRISE 193
15.3.1 COMPANY OVERVIEW 193
15.3.2 FINANCIAL OVERVIEW 193
15.3.3 PRODUCTS OFFERED 194
15.3.4 KEY DEVELOPMENTS 194
15.3.5 SWOT ANALYSIS 195
15.3.6 KEY STRATEGIES 195
15.4 CLARIANT 196
15.4.1 COMPANY OVERVIEW 196
15.4.2 FINANCIAL OVERVIEW 197
15.4.3 PRODUCTS OFFERED 197
15.4.4 KEY DEVELOPMENTS 198
15.4.5 SWOT ANALYSIS 199
15.4.6 KEY STRATEGIES 199
15.5 LALLEMAND INC. 200
15.5.1 COMPANY OVERVIEW 200
15.5.2 FINANCIAL OVERVIEW 200
15.5.3 PRODUCTS OFFERED 200
15.5.4 KEY DEVELOPMENTS 201
15.5.5 SWOT ANALYSIS 202
15.5.6 KEY STRATEGIES 202
15.6 HEIQ 203
15.6.1 COMPANY OVERVIEW 203
15.6.2 FINANCIAL OVERVIEW 203
15.6.3 PRODUCTS OFFERED 204
15.6.4 KEY DEVELOPMENTS 204
15.6.5 KEY STRATEGIES 204
15.7 SILAB 205
15.7.1 COMPANY OVERVIEW 205
15.7.2 FINANCIAL OVERVIEW 205
15.7.3 PRODUCTS OFFERED 206
15.7.4 KEY DEVELOPMENTS 206
15.7.5 KEY STRATEGIES 206
15.8 SABINSA CORPORATION 207
15.8.1 COMPANY OVERVIEW 207
15.8.2 FINANCIAL OVERVIEW 207
15.8.3 PRODUCTS OFFERED 207
15.8.4 KEY DEVELOPMENTS 208
15.8.5 KEY STRATEGIES 208
15.9 ROELMI HPC 209
15.9.1 COMPANY OVERVIEW 209
15.9.2 FINANCIAL OVERVIEW 209
15.9.3 PRODUCTS OFFERED 209
15.9.4 KEY DEVELOPMENTS 209
15.9.5 KEY STRATEGIES 209
15.10 PURIPHARM 210
15.10.1 COMPANY OVERVIEW 210
15.10.2 FINANCIAL OVERVIEW 210
15.10.3 PRODUCTS OFFERED 210
15.10.4 KEY DEVELOPMENTS 210
15.10.5 KEY STRATEGIES 210
16 COMPANY PROFILES OF BUYERS 211
16.1 L’ORÉAL SA. 211
16.1.1 COMPANY OVERVIEW 211
16.1.2 FINANCIAL OVERVIEW 212
16.1.3 KEY DEVELOPMENTS 213
16.1.4 SWOT ANALYSIS 213
16.1.5 KEY STRATEGIES 213
16.2 THE ESTÉE LAUDER COMPANIES INC. 214
16.2.1 COMPANY OVERVIEW 214
16.2.2 FINANCIAL OVERVIEW 215
16.2.3 PRODUCTS OFFERED 215
16.2.4 KEY DEVELOPMENTS 216
16.2.5 THE ESTÉE LAUDER COMPANIES INC. 216
16.2.6 KEY STRATEGIES 217
16.3 AMOREPACIFIC CORP 218
16.3.1 COMPANY OVERVIEW 218
16.3.2 FINANCIAL OVERVIEW 218
16.3.3 KEY DEVELOPMENTS 219
16.3.4 SWOT ANALYSIS 219
16.3.5 KEY STRATEGIES 220
16.4 TULA LIFE INC. 221
16.4.1 COMPANY OVERVIEW 221
16.4.2 FINANCIAL OVERVIEW 221
16.4.3 PRODUCTS OFFERED 221
16.4.4 KEY DEVELOPMENTS 223
16.4.5 KEY STRATEGIES 223
16.5 GALLINÉE MICROBIOME SKINCARE 224
16.5.1 COMPANY OVERVIEW 224
16.5.2 FINANCIAL OVERVIEW 224
16.5.3 PRODUCTS OFFERED 224
16.5.4 KEY DEVELOPMENTS 224
16.5.5 KEY STRATEGIES 225
16.6 ESSE SKINCARE 226
16.6.1 COMPANY OVERVIEW 226
16.6.2 FINANCIAL OVERVIEW 226
16.6.3 PRODUCTS OFFERED 226
16.6.4 KEY DEVELOPMENTS 227
16.6.5 KEY STRATEGIES 228
16.7 YUN PEROBIOTHERAPY 229
16.7.1 COMPANY OVERVIEW 229
16.7.2 FINANCIAL OVERVIEW 229
16.7.3 PRODUCTS OFFERED 229
16.7.4 KEY DEVELOPMENTS 229
16.7.5 KEY STRATEGIES 229
16.8 AURELIA SKINCARE LTD 230
16.8.1 COMPANY OVERVIEW 230
16.8.2 FINANCIAL OVERVIEW 230
16.8.3 PRODUCTS OFFERED 230
16.8.4 KEY DEVELOPMENTS 230
16.8.5 KEY STRATEGIES 230
16.9 LAFLORE PROBIOTIC SKINCARE 231
16.9.1 COMPANY OVERVIEW 231
16.9.2 FINANCIAL OVERVIEW 231
16.9.3 PRODUCTS OFFERED 231
16.9.4 KEY DEVELOPMENTS 231
16.9.5 KEY STRATEGIES 231
16.10 NEOGENLAB 232
16.10.1 COMPANY OVERVIEW 232
16.10.2 PRODUCTS OFFERED 232
16.10.3 KEY DEVELOPMENTS 232
16.10.4 KEY STRATEGIES 232
17 APPENDIX 233
17.1 REFERENCES 233
17.2 RELATED REPORTS 233
Companies Mentioned
DSM (Netherland), BASF SE (Germany), Sabsinsa Corporation (US), Rolemi HPC (Italy), Puripharm. (China), L’oreal S.A.(France), HeIQ (Switzerland), Silab (France), Amorepacific Group (South Korea), TULA Life Inc. (US), Gallinée Microbiome Skincare (UK), ESSE SKINCARE (South Africa), Yun Perobiotherapy (Belgium), Estée Lauder Companies Inc. (US), Symrise (Germany), Clariant (Switzerland), Lallemand Inc. (Canada),Aurelia Skincare Ltd (UK), LaFlore Probiotic Skincare (US), Neogenlab (US)
Reviews
There are no reviews yet.